You are probably wondering about psilocybin companies to invest in. Think back to several years ago when marijuana was illegal in almost every country in the world, with only a few daring to explore it’s potential in the world of medicine.
Fast forward to today and marijuana is used to treat several diseases and conditions, including epilepsy, sleeping disorders, asthma, cancer, digestive issues, chronic pain, multiple sclerosis, glaucoma and many more. The best part about it is that this is just the tip of the iceberg and scientists still have a lot more to learn about this herb.
Investors around the world have pumped billions of dollars into research and several companies dedicated to medicinal marijuana have popped up over the years. Since the legalization/ decriminalization of recreational marijuana in many parts of the world, including Canada and the United States, many companies have branched off into the manufacturing and distribution of recreational marijuana. It should come as no surprise to you that these same companies have entered stock markets and are worth billions today. In fact, these publicly traded companies have been trending these past few years and have worked there way into many investment discussions across the continent.
Can psychedelics follow this trend? Are there even Psilocybin companies to invest in?
Multi-millionaire Kevin O’Leary seems to think so and has invested in a company called Mind Med. MindMed’s mission is to discover and develop new medicines based on psychedelics. This microdosing can potentially help cure opioid addiction, treat alcoholism, depression and potentially Alzheimer’s.
In this article, we’ll look at why you should seriously consider investing in psychedelics and even throw in a few Psilocybin companies to invest in
But before we do that, let’s clear up some things, starting with what psychedelics are:
What are psychedelics?
You may have heard of (or even tried) shrooms (mushrooms), LSD, acid, DMT or MDMA.
These fall under a category of drugs known as Psychedelics. The word psychedelic stems from the Greek words ‘psyche’ and ‘delos’ which mean mind and reveal respectively since these drugs can alter a person’s perception or mood and can even affect certain cognitive processes.
Psychedelics have been around for a very long time and have been used by different cultures in some form or another, so it’s nothing new. During this time a considerable amount of research and studies were conducted on the effects these drugs have on the body and the potential for use in treatment. By the time the 70’s came along, all this came to a halt with Nixon’s war on drugs. Suddenly samples were hard to get for scientists to continue their research and funding was cut.
The message sent to the public was that “Psychedelics are bad”.
Why the change of heart?
Remember when marijuana was this “bad” drug used only by degenerates and the scum of society? That was the message that was put out after all. Now, marijuana is even being used to prevent seizures in infants.
In excess, marijuana does have negative side effects but once regulated and administered in correct proportions, the benefits far outweigh the risks. It’s pretty much the same concept for psychedelics and anything else really. An apple a day keeps the doctor away, but eating too many apples can give you an upset stomach.
Moderation is key to everything in life. Take a panadol or any over-the-counter pain medication for instance. You’re told to take one or two and that should ease your pain, but taking too much can lead to a night in the hospital or even worse, a permanent spot in a cemetery.
So if marijuana, why not psychedelics? Some states in the US such as Colorado and California have taken some steps in this direction by decriminalizing psilocybin (magic mushrooms).
Across the pond in London and even in Germany, other companies have been working on medicines that they hope can be used to change the way certain diseases are treated.
The “Shroom Boom”, why invest?
When Colombus set off on his journey to the New World, there were many naysayers. The Portuguese refused him, the English refused him, the French refused him and the Italians too.
But as crazy as his idea sounded at the time,
the truth is everyone was tuned in to see what would happen. Would he fall off the edge of the earth, or would he find riches beyond the wildest of dreams?
When he sailed back to Europe, he brought back with his tales of all he had seen and more importantly, proof that there was wealth to be had in this New World. It wasn’t long till all the countries who rejected him sent their expeditions to this New World to get a share of this wealth.
With psychedelics, scientists have proven that it can be effective in treating certain conditions, and is safe once administered as prescribed. The only thing in the way is legislation, and in time it too will change.
The Spanish crown gave Columbus the go-ahead and got super-wealthy off it. This left the other European countries who rejected him having to play catch up.
In this day and age, would you prefer to be the Spanish, and get the first taste of the profits of Psilocybin companies to invest in, or will you wait like the Portuguese who could’ve, should’ve, but didn’t?
Where can I invest? Psilocybin companies to invest in
Since psychedelics aren’t fully legalized across the U.S and Canada, the list of companies that are publicly traded is a bit short. Here are a few Psilocybin companies to invest in or keep your eye on:
Roadman Investment Corp
Listed TSX-V: LITT
Roadman Investments invests in companies that focus on health and wellness, nutrition, new medicines, pharmaceuticals, and so forth. Its plans involve expanding into the medicinal mushroom sectors in areas such as cultivation, distribution, research, and development.
The Yield Grow Corp
Listed CSE: BOSS
While this company is focused primarily on marijuana, it has branched out into psychedelics and has acquired a 50-year license to produce a variety of psilocybin/psilocin infused products from food and beverages to cosmetics.
Listed CSE: GBLC
Graph Blockchain focuses primarily on developing private blockchain solutions but has branched out into psychedelics with its proposed acquisition of Shroom Street Limited. Shroom Street Limited is a psychedelic based company, with its hands in e-commerce, lifestyle and reporting the developments in the world of psychedelics.
Wuhan General Group China Inc
Listed OTCUS: WUHN
Located in Wuhan, China, this company specializes in alternative medicine including the production and export of CBD and psilocybin targeted at patients who suffer from conditions such as Alzheimer’s, Parkinson’s, mental disorders, chronic pain, and cancer. Tremendous growth and expansion to North America, South Africa, and Europe are to be expected so this is definitely atop the list of Psilocybin companies to invest in for the long run.
While not listed, don’t be surprised if you hear about these Psilocybin companies to invest in in the future:
Frontier Neurochem, CaaMTech, Tasssili Life Science Corp and Entheon Biomedical
Companies outside of North America that are worth mentioning are Compass Pathways, Mind Medicine Australia and The Center for Psychedelic Research at Imperial College London.
Now that you have an idea of which Psilocybin companies to invest in, it is time to move on to the next step.
Every good investor knows that the key to making great business moves is patience and it will probably be a while before you see any big profit. Take this time to pay close attention to any developments and new legislation that can affect the growth of this sector or these Psilocybin companies to invest in